IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q4 2019 Holdings

Filed 2020-02-05 | 5 holdings | $607.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$521.3K6,837,25385.8%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$40.4K1,672,7146.7%
Insmed Incorporated(INSM)COM457669307$21.0K880,0163.5%
Epizyme, Inc.(EPZMEUR)COM29428V104$14.5K591,3042.4%
Acceleron Pharma Inc.(XLRN)COM00434H108$10.0K188,6021.6%